0001209191-19-003905.txt : 20190116
0001209191-19-003905.hdr.sgml : 20190116
20190116142908
ACCESSION NUMBER: 0001209191-19-003905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190114
FILED AS OF DATE: 20190116
DATE AS OF CHANGE: 20190116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital IV, L.P.
CENTRAL INDEX KEY: 0001456590
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 19528949
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2211
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Side Fund IV, L.P.
CENTRAL INDEX KEY: 0001456591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 19528950
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2211
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures IV, LLC
CENTRAL INDEX KEY: 0001456589
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 19528951
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2211
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-14
0
0001410939
Ophthotech Corp.
OPHT
0001456590
Versant Venture Capital IV, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001456591
Versant Side Fund IV, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001456589
Versant Ventures IV, LLC
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
Common Stock
2019-01-14
4
J
0
129709
2.2984
A
5142333
I
See footnote
Common Stock
2019-01-14
4
J
0
817
2.2984
A
32394
I
See footnote
On January 14, 2019, the Reporting Persons received an additional 130,526 shares of Ophthotech Corporation ("Ophthotech") common stock as a result of the post-closing adjustment as provided for in that certain Agreement and Plan of Merger dated October 30, 2018, by and among Ophthotech, Inception 4, Inc. and the other parties thereto. No additional consideration was paid for such shares. The Reporting Persons' right to receive additional shares became fixed and irrevocable on October 30, 2018, the effective date of the merger.
This report on Form 4 is jointly filed by Versant Venture Capital IV, L.P. ("VVC IV") and Versant Side Fund IV, L.P. ("VSF IV"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such entity is a beneficial owner of such securities for the purpose of Section 16 or for any other purpose.
These securities are held of record by VVC IV. Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley Bolzon, Ph.D., Charles M. Warden, Kirk G. Nielsen, Thomas Woiwode and Robin L. Praeger are managing directors of VV IV and share voting and dispositive power over the shares held by VVC IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
These securities are held of record by VSF IV. VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley Bolzon, Ph.D., Charles M. Warden, Kirk G. Nielsen, Thomas Woiwode and Robin L. Praeger are managing directors of VV IV and share voting and dispositive power over the shares held by VSF IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
/s/ Robin L. Praeger, Managing Director of Versant Ventures IV, LLC, general partner of Versant Venture Capital IV, L.P.
2019-01-16
/s/ Robin L. Praeger, Managing Director of Versant Ventures IV, LLC, general partner of Versant Side Fund IV, L.P.
2019-01-16
/s/ Robin L. Praeger, Managing Director of Versant Ventures IV, LLC
2019-01-16